Upload
others
View
4
Download
0
Embed Size (px)
Citation preview
Antimicrobial stewardship and
infection control in the ICU
HAI short course
CIDM-PH/ SEIB
antibiotic effects
• antibiotics drive resistance that can persist
• some are worse than others
• stewardship is complex and ill-informed
increased resistance
Costelloe C et al. BMJ.
2010;340:c2096.
antibiotic effects
• antibiotics drive resistance that can persist
• some are worse than others
• stewardship is complex and ill-informed
streptococci and friends (incl. lactococci and staph)E. coli and friends
funny things we don’t think about much like propionibacteria
infecting populations
n
infecting populations
t
quinolones?
3GC?
(eg.
(MRSA
•niche competition
•displacement
•niche competition
•not consistent with
evidence for
ecological integrity
(MRSA
(P. aeruginosa
(outside clones•large potential reservoir; not enabled
•not consistent with
•evidence for old genes
•evidence in gene capture system
•large potential reservoir; enabled
•is consistent with
•evidence for old genes
•evidence in gene capture systems
antibiotic effects
• antibiotics drive resistance that can persist
• some are worse than others
• stewardship is complex and ill-informed
complexities of stewardship
• variable perturbations in robust dynamic systems
• niche specificity exists at multiple levels
• anthropocentric view of ‘medically important bacteria’ vs • anthropocentric view of ‘medically important bacteria’ vs
responsible husbandry of a complex ecosystem
• adaptive strategies vary with bug and drug
(genome) size does matter
• GPC – think opportunism, environmental control/ fomites; surveillance is simple
• Enterobacteriaceae – think selection pressure, resistance potential
eg MRSA (S. aureus) – tough, predictable, common but not universal, mostly a solo operator (clonal outbreaks)
eg E.coli, Klebsiella – universal but adaptable, not so tough but a real team player (clonal R outbreaks unusual)pressure, resistance potential
• “non-fermenters” (Acb, PA etc) – think environmental control, real-time adaptive responses, selection pressure
eg Pseudomonas, Acinetobacter – tough, adaptable, versatile – as a solo or team operator (clonal and polyclonal R outbreaks)
HICSIG
Hospital Infection Control
Special Interest Group
of the
Australian Society
for Infectious Diseases
Clinical outcomes better with antimicrobial management program
Perc
en
t
RR 2.8 (2.1-3.8) RR 1.7 (1.3-2.1) RR 0.2 (0.1-0.4)
Perc
en
t
AMP = Antibiotic Management Program
UP = Usual PracticeFishman N. Am J Med. 2006;119:S53.
Improving antibiotic use saves money
• “Comprehensive programs have consistently demonstrated a decrease in antimicrobial use with annual savings of $200,000 -$900,000”$900,000”
• IDSA/SHEA Guidelines for Antimicrobial Stewardship Programs
• http://www.journals.uchicago.edu/doi/pdf/10.1086/510393
Stewardship optimizes patient safety: decreased patient-level resistance
Cipro Standard
Antibiotic duration
3 days 10 days
LOS ICU 9 days 15 days
Antibiotic resistance/ superinfection
14% 38%
Study terminated early because attending
physicians began to treat standard care group
with 3 days of therapy
Singh N et al. Am J Respir Crit Care Med. 2000;162:505-11.
antibiotics in ICU
• most (90% ID / 74% ICU) agree1: – ab R is a clinical problem that needs action
– local susceptibility data are essential• only 68% ID / 39% ICU used local databases
• current advice not very useful / accessible– 64% ICU consult ID;
• 25% find that advice to be generally unhelpful1
• 13% Rx informed by MC/S (unpub.)
• better data with prescriber guidelines– improves antibiotic prescribing
– reduces ICU length of stay2,3
1. Sintchenko et al. IJAA 2001, 2. Sintchenko et al. JAMIA 04 3. Sintchenko et al. JAMIA 05
Liaison rounds
•Face-to-face(best) or teleconferenced; twice weekly or more in large units. Ensure ALL
intensive care units receive ID and Clinical Microbiologist input.
•At each round: bed by bed.
•Examine clinical situation, what the function of treatment is (prophylaxis, empiric or
directed treatment). Review previous decisions and patient outcome as required.
•Recommend necessary changes - switches to directed treatment, cessation of •Recommend necessary changes - switches to directed treatment, cessation of
prophylaxis, cessation/end dates for empiric or directed treatment. Where possible
tie treatment plans back to existing guidelines.
•what the microbiology and other tests show.
•Recommend additional investigations in potentially undiagnosed infection
•Be mindful of necessary infection control procedures (hand hygiene) during the round
- ensure compliance by visiting liaison staff - provide an example!
•Document the round decisions - [ eg entry/ sticker in medical record]
culture clashes
• the individual good vs the common good
• power and control/ personality effects
• sovereign immunity vs accountability
Reducing 3GC use usually involves a switch to aminoglycosides.
Advantages:
•aminoglycosides generally broader Gram negative spectrum
•aminoglycosides are rapidly bactericidal
•benefit of dual therapy in septic shock (b-lactam + aminoglycosides)•benefit of dual therapy in septic shock (b-lactam + aminoglycosides)
•nephrotoxicity of aminoglycosides correlates with duration of use and is very
low following 1-3 daily doses
•ECF-distributed and low GI penetration/ ecological impact
Craig and Andes
Semin Resp Infect 1997; 12 (4): 271-
Kumar et al
Crit Care Med. 2010 Sep;38(9):1773-85
3GC3GC
3GC
SMH Sydney 2012 …clinicians clean up after massive 3GC exposure in ICU
main messages
• some drugs are just bad news
• protocols can protect
• prevention is a moment in time
• keep it simple